GlobeNewswire by notified

PRESS RELEASE: Tectia Quantum Safe Edition released with next-generation encryption algorithms

Share

Tectia Quantum Safe Edition released with next-generation encryption algorithms

SSH Communications Security announces the release of Tectia version 6.6, The Quantum Safe Edition. Tectia Quantum Safe Edition tackles new rising cyber threats and ensures future-proof data security. A related Edition, Tectia Zero Trust, was already implemented in Tectia version 6.5 in March 2022. 

These new additions to the Tectia product family will ensure that SSH’s secure remote access solutions are futureproof and meet the challenges posed by quantum computing and cloudification.

A new rising threat to cybersecurity 

The new threat customers face is recording attacks on current cryptography. Quantum Computers are not yet usable for breaking encryption, but data traffic can be recorded and decrypted later in a short period of time, compromising secrets with long-term value. 

With Tectia 6.6, organizations can prepare for new threats and ensure the safety of critical data. Tectia Quantum Safe Edition protects critical remote access, file transfers, and tunneling connections against the quantum threat already today.

SSH by SSH Communications Security 

Secure Shell (SSH) protocol enables online connections and file transfers between applications handling critical data. Tectia is the original commercial implementation of the SSH protocol. 

“Tectia Quantum Safe Edition 6.6 is now available to our customers. Supported by our Zero Trust access control platform, the product efficiently combats new threats against traditional encryption. Quantum Safe addresses the next challenge in cybersecurity and guarantees the safety of critical data,” says Dr. Teemu Tunkelo, SSH CEO. 

“Some of our customers, like some distinguished banks, are deploying the solution in the first wave because they want to remain futureproof.  The cybersecurity landscape is becoming increasingly challenging, which causes our customers in many other market segments to respond,” Teemu concludes.

Tectia Quantum Safe Edition is available to customers from June 15, 2022. You can request a demo or a quote on the product by contacting the SSH team or visiting our website. 

For more information on Tectia Quantum Safe Edition, please visit: Tectia® SSH Client/Server Quantum Safe Edition

Learn more about Tectia: Tectia® SSH Client/Server


For further information, please contact: 

Teemu Tunkelo, CEO, tel. +358 40 5499605, email Teemu.Tunkelo@ssh.com
Jussi Rautio, Tectia Product Manager email Jussi.Rautio@ssh.com 


Distribution: 
Major media 
www.ssh.com


About SSH
SSH helps organizations safeguard their mission-critical digital assets at rest, in transit and in use. We have 5,000+ customers worldwide, including 40 percent of Fortune 500 companies, and major organizations in Finance, Government, Retail, and Industrial segment. We are committed to helping our customers secure their business in the age of hybrid cloud and distributed IT and OT solutions. Our Zero Trust solutions offer safe electronic communications, secure access to servers and between servers. Our teams in North America, Europe, Asia along with a global network of certified partners ensure customer success. The company’s shares (SSH1V) are listed on Nasdaq Helsinki. www.ssh.com.  

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Huhtamaki publishes 2022 Half-yearly Report on July 21, 202230.6.2022 09:00:00 CEST | Press release

HUHTAMÄKI OYJ PRESS RELEASE 30.6.2022 AT 10:00 Huhtamaki publishes 2022 Half-yearly Reporton July21, 2022 Huhtamäki Oyj will publish its 2022 Half-yearly Report on Thursday, July 21, 2022, approximately at 8.30 am Finnish time (EEST). The release and related results presentation material will be available after publishing at www.huhtamaki.com/investors. Teleconference Huhtamaki will arrange a combined audiocast and teleconference on the same day at 9.30 am Finnish time, where the company’s management will present the results. The event will be followed by a Q&A session. The event will be held in English, it can be followed real-time at: https://huhtamaki.videosync.fi/2022-q2 If you wish to ask questions, please dial one of the following numbers 5-10 minutes prior to the call start: Finland Toll: +358981710310 Sweden Toll: +46 856642651 United Kingdom Toll: +44 3333000804 United States Toll: +1 6319131422 Confirmation code for the call is 23337170# An on-demand replay of the audiocast w

Fingerprints announces design win for its optical under-display solution with major Asian smartphone OEM30.6.2022 08:00:00 CEST | Press release

Fingerprint Cards AB (Fingerprints™) today announced that it has secured a design win* for its optical under-display solution, FPC 1632, with a major Asian smartphone OEM, following successful qualification tests earlier this year. We expect to commence shipments during the fourth quarter of 2022. “Since many years, Fingerprints is a well-established world leader in capacitive fingerprint sensors. The design win we are announcing today marks our entry into a new market segment: optical under-display fingerprint sensors. This will open up attractive new growth opportunities for us going forward, and our goal is to capture a significant share of this market,” says Ted Hansson, President Mobile, PC & Access China at Fingerprints. For more information about Fingerprints’ mobile device solutions, visit the website. * Fingerprints’ definition of Design Win (DW): The decision by a device vendor (OEM or ODM) to start development of one or several commercial product(s) incorporating Fingerprint

Inaugural Yara Clean Ammonia Capital Markets Day30.6.2022 08:00:00 CEST | Press release

Oslo, 30 June 2022: Today, Yara International ASA (“Yara”) will host a Capital Markets Day (“CMD”) for Yara Clean Ammonia (“YCA” or the “Company”). During the event, members of YCA’s management team will present key features of the Company, including its strategy and growth ambitions, as well as financial parameters and targets for the future. In May 2022, Yara announced that it is evaluating a potential initial public offering (“IPO”) of YCA on the Oslo Stock Exchange. “While the decision to list YCA will be made in due course, Yara is now excited to host an inaugural CMD for YCA to showcase their exciting story,” said Svein Tore Holsether, CEO and President of Yara. “YCA combines a leading midstream business with exceptional growth prospects and a value creating project portfolio.” Key highlights: Clean ammonia represents a massive opportunity that is projected to drive exponential, long-term market growth [1].YCA comprises existing cash flows from a market leading position [2] in a

Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial of UV1 in Malignant Melanoma30.6.2022 08:00:00 CEST | Press release

Full recruitment of 154 patients with malignant melanoma in U.S. and Europe in 24 monthsStudy provides randomized data on impact of UV1 on standard-of-care immunotherapy Topline progression-free survival data expected H1 2023 Oslo, 30 June 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces the completed recruitment of 154 patients in the INITIUM trial. INITIUM is Ultimovacs’ Phase II clinical trial of its universal cancer vaccine UV1 in combination with the checkpoint inhibitors ipilimumab and nivolumab in metastatic malignant melanoma. Consistent with INITIUM’s event-driven design, topline progression-free survival results will be disclosed after progression of cancer or death has been observed in a total of 70 patients. “It is a remarkable achievement that Ultimovacs and its clinical partners have completed recruitment to INITIUM largely on schedule despite challenges caused by the pandemic,” said Carlos de Sou